Available IPD datapackage for study 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With a Sulfonylurea in Subjects With Type 2 Diabetes'
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00002452_0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), combined with a sulfonylurea in adults with type 2 diabetes mellitus.
本研究旨在评估每日一次（QD）的阿格列汀（alogliptin）联合磺脲类药物（sulfonylurea）治疗成人2型糖尿病的有效性与安全性
提供机构：
Vivli
创建时间：
2022-01-11
